CN Stock MarketDetailed Quotes

688621 Beijing Sun-Novo Pharmaceutical Research

Watchlist
  • 39.50
  • -0.79-1.96%
Market Closed Dec 27 15:00 CST
4.42BMarket Cap19.98P/E (TTM)

Beijing Sun-Novo Pharmaceutical Research Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beijing Sun-Novo Pharmaceutical Research Q3 2024 Earnings Date

Currency：CNYOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
353.82M
--
+53.20%
EPS
--
0.52
--
--
Analyst Rating
Strong Buy

Dec 27, 2024

Beijing Sun-Novo Pharmaceutical Research Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/FY953.898M / 927.333M--
Mar 11, 20232022/FY676.606M / 689.000M--
--2020/FY347.356M / ----
DatePeriodRevenue/EstimateEarnings Call
--2023/FY953.898M / 927.333M--
Mar 11, 20232022/FY676.606M / 689.000M--
--2020/FY347.356M / ----
--------
--------

Unlock Free Earnings Estimates

Beijing Sun-Novo Pharmaceutical Research Earnings Reports

  • Sunshine Novo: Third Quarter Report 2024

    Oct 28 12:00 ET

  • Third Quarter Report 2024

    Oct 28 12:00 ET

  • 2024 Semi-Annual Report

    Aug 29 12:00 ET

  • 2024 Semi-Annual Report Summary

    Aug 29 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 27, 2024

    Strong Buy

    • Strong Buy

      84.62%

    • Buy

      15.39%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Innovative Drugs
    Innovative Drugs
    Intraday+0.47%